News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
642,754 Results
Type
Article (28956)
Company Profile (200)
Press Release (613595)
Multimedia
Podcasts (63)
Webinars (11)
Section
Business (209003)
Career Advice (728)
Deals (31466)
Drug Delivery (92)
Drug Development (65296)
Employer Resources (74)
FDA (13742)
Job Trends (12699)
News (301790)
Policy (28868)
Tag
2025 Best Places to Work (16)
2026 Best Places to Work (25)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (2141)
Academic (2)
Accelerated approval (54)
ADA (40)
Adcomms (18)
Allergies (166)
Alliances (43270)
ALS (165)
Alzheimer's disease (1568)
Antibody-drug conjugate (ADC) (467)
Approvals (14503)
Artificial intelligence (689)
ASCO (206)
Autoimmune disease (338)
Automation (62)
Bankruptcy (314)
Belgium (19)
Best Places to Work (10435)
BIO (51)
Biologics (90)
BIOSECURE Act (7)
Biosimilars (219)
BioSpace Insights (69)
Biotechnology (107)
Bispecific (50)
Bladder cancer (172)
Brain cancer (60)
Breast cancer (738)
Cancer (5539)
Cardiovascular disease (467)
Career advice (649)
Career pathing (19)
CAR-T (254)
CDC (73)
CDMO (91)
Celiac Disease (6)
Cell-line development (1)
Cell therapy (724)
Cervical cancer (63)
Clinical research (58973)
Collaboration (2117)
Commercialization (59)
Company closure (4)
Compensation (1711)
Complete response letters (54)
COVID-19 (2366)
CRISPR (113)
CRO (5)
C-suite (1191)
Cystic fibrosis (132)
Data (8765)
Decentralized trials (3)
Denatured (18)
Depression (182)
Dermatology (176)
Diabetes (637)
Diagnostics (6537)
Digital health (80)
Diversity (7)
Diversity, equity & inclusion (25)
Drug discovery (302)
Drug pricing (164)
Drug shortages (14)
Duchenne muscular dystrophy (264)
Earnings (89285)
Editorial (48)
Employer branding (9)
Employer resources (71)
ESMO (291)
Events (108626)
Executive appointments (1040)
Eye disease (15)
FDA (17825)
Fibrodysplasia Ossificans Progressiva (14)
Fragile X (2)
Friedreich's ataxia (25)
Frontotemporal dementia (31)
Funding (1708)
Gene editing (206)
Generative AI (49)
Gene therapy (538)
GLP-1 (781)
Government (4514)
Grass and pollen (6)
Guidances (415)
Healthcare (17429)
Hematology (161)
HIV (99)
Huntington's disease (43)
Idiopathic pulmonary fibrosis (9)
IgA nephropathy (112)
Immunology and inflammation (197)
Immuno-oncology (97)
Indications (250)
Infectious disease (2744)
Inflammatory bowel disease (213)
Inflation Reduction Act (11)
Influenza (148)
Intellectual property (324)
Interviews (89)
IPO (15173)
IRA (34)
Job creations (2669)
Job search strategy (575)
JPM (17)
Kidney cancer (23)
Kidney disease (133)
Labor market (53)
Layoffs (281)
Leadership (15)
Legal (7066)
Licensing (117)
Liver cancer (74)
Longevity (47)
Lung cancer (772)
Lung diease (22)
Lymphoma (392)
Machine learning (46)
Management (25)
Manufacturing (962)
Marketing (37)
MASH (199)
Medical affairs (5)
Medical device (11986)
Medtech (12257)
Melanoma (76)
Mergers & acquisitions (17660)
Metabolic disorders (1454)
Middle East (1)
mRNA (189)
Multiple sclerosis (171)
Multispecific (4)
NASH (10)
Netherlands (20)
Neurodegenerative disease (368)
Neuropsychiatric disorders (83)
Neuroscience (3033)
Neurotech (2)
NextGen: Class of 2026 (5644)
Non-profit (3915)
Now hiring (16)
Obesity (595)
Opinion (155)
Ovarian cancer (218)
Pain (259)
Pancreatic cancer (317)
Parkinson's disease (322)
Partnered (24)
Patents (632)
Patient advocacy (8)
Patient recruitment (712)
Patient selection (83)
Peanut (55)
People (52884)
Peptides (36)
Pharmaceutical (47)
Pharmacy benefit managers (39)
Phase 1 (18221)
Phase 2 (25761)
Phase 3 (19133)
Pipeline (12217)
Policy (274)
Postmarket research (2272)
Preclinical (7675)
Press Release (47)
Prostate cancer (295)
Psychedelics (67)
Radioligand (1)
Radiopharmaceuticals (304)
Rare diseases (1021)
Real estate (4338)
Recruiting (28)
Regenerative medicine (23)
Regulatory (22847)
Reports (46)
Research institute (2040)
Resumes & cover letters (81)
Rett syndrome (50)
RNA editing (16)
RSV (81)
Saudi Arabia (1)
Schizophrenia (167)
Series A (273)
Series B (202)
Service/supplier (6)
Sickle cell disease (122)
Special edition (14)
Spinal muscular atrophy (127)
Sponsored (28)
Startups (2858)
Stem cells (5)
Stomach cancer (7)
Substance use disorders (22)
Supply chain (101)
Switzerland (14)
Tariffs (44)
Tax incentives (1)
The Weekly (44)
Vaccines (1097)
Venture capital (75)
Weight loss (343)
Wet AMD (6)
Women's health (178)
Worklife (8)
Date
Last 7 days (538)
Last 30 days (2864)
Last 365 days (25319)
2026 (23424)
2025 (25200)
2024 (29611)
2023 (33996)
2022 (43710)
2021 (48277)
2020 (47351)
2019 (39375)
2018 (29422)
2017 (25693)
2016 (25752)
2015 (32004)
2014 (27370)
2013 (22531)
2012 (24592)
2011 (25151)
2010 (24418)
Location
Africa (612)
Alabama (97)
Alaska (5)
Arizona (410)
Arkansas (15)
Asia (29778)
Australia (4689)
California (15096)
Canada (4185)
China (1132)
Colorado (670)
Connecticut (631)
Delaware (350)
Europe (55736)
Florida (2287)
Georgia (497)
Hawaii (4)
Idaho (66)
Illinois (1197)
India (113)
Indiana (663)
Iowa (32)
Japan (645)
Kansas (137)
Kentucky (59)
Louisiana (60)
Maine (92)
Maryland (1757)
Massachusetts (10278)
Michigan (385)
Minnesota (814)
Mississippi (6)
Missouri (149)
Montana (30)
Nebraska (22)
Nevada (173)
New Hampshire (79)
New Jersey (3873)
New Mexico (20)
New York (3927)
North Carolina (1766)
North Dakota (9)
Northern California (7683)
Ohio (437)
Oklahoma (24)
Oregon (35)
Pennsylvania (2908)
Puerto Rico (30)
Rhode Island (47)
South America (837)
South Carolina (92)
South Dakota (2)
Southern California (6266)
Tennessee (217)
Texas (2539)
United States (52239)
Utah (459)
Vermont (1)
Virginia (300)
Washington D.C. (70)
Washington State (1219)
West Virginia (4)
Wisconsin (136)
Wyoming (5)
642,754 Results for "health net inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RECORDATI FIRST NINE MONTHS 2026: NET REVENUE +7.5%, EBITDA +7.7%, ADJUSTED NET INCOME +6.4%
November 10, 2026
·
23 min read
IPO
Windward nets $175M IPO, bringing 2026 biotech debuts to 35
Windward Bio’s public debut brings this year’s IPO count well above the sluggish total of eight in 2025.
November 13, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Galderma Delivers Net Sales of 4.765 B USD in the First Nine Months, Up 25.1% at Constant Currency Year-on-Year, and Raises Full-Year Net Sales Guidance
October 22, 2026
·
17 min read
Press Releases
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
October 28, 2026
·
18 min read
Press Releases
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax
November 10, 2026
·
13 min read
Press Releases
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026
October 13, 2026
·
3 min read
Press Releases
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
November 10, 2026
·
5 min read
Press Releases
KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA
November 10, 2026
·
15 min read
Press Releases
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
August 26, 2026
·
8 min read
Press Releases
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
July 28, 2026
·
21 min read
1 of 64,276
Next